FFAR4 and metabolic dysfunction-associated steatotic liver disease: The findings of this study highlight the underlying mechanism of FFAR4-mediated gut–liver crosstalk involved in the occurrence of NALFD and provide new ideas for the study of FFAR4 as a therapeutic target for NAFLD.